1. Smith, R, and J. Coast. "Antimicrobial resistance: a global response." Bulletin of the World Health Organization. 80.2 (2002): 126-133. Web. 29 Mar. 2012.
2. "Antimicrobial Resistance ." World Health Organization. WHO, Mar 2012. Web. 29 Mar 2012.
3. "How Antibiotic Resistance Happens." Save Antibiotics. The Pew Campaign on Human Health and Industrial Farming. Web. 29 Mar 2012.
4. "Gene Transfer Facilitates the Spread of Drug Resistance" Save Antibiotics. The Pew Campaign on Human Health and Industrial Farming. Web. 29 Mar 2012.
5. Spellberg, B. "Combating Antimicrobial Resistance: Policy Recommendations to Save Lives." Clinical Infectious Diseases. 52.5 (2011): 397-428. Web. 29 Mar. 2012.
6. Sharma, S, and a Mohan. "Multidrug-Resistant Tuberculosis a Menace That Threatens to Destabilize Tuberculosis Control." CHEST. 130.1 (2006): 261-272. Web. 29 Mar. 2012.
The study reported by Innovative BioDefense Inc. states that studies have demonstrated that Zylast, a line of antimicrobial products has been found after an extensive time-kill testing on the Zylast products that more than 99.9% of disease causing germs were destroyed within 15 seconds, making Zylast the most effective antimicrobial on the market. Stated to be included in the microbacteria that Zylast products are effective against is that of Pseudomonas aeruginosa (2 versions) -- "A dangerous bacteria that thrives on medical equipment and catheters and is a major source of nosocomial infection, this gram-negative bacteria can be fatal if infecting a vital organ." (p.1)
(10) McGeer, A and Fleming, CA (2011) Antimicrobial Resistance in Common Hospital Pathogens in Ontario. Quality Management Program -- Laboratory Services, Department of the Ontario Medial Association. April 2012. Retrieved from: http://www.qmpls.org/Portals/0/Knowledge%20Centre/Antimicrobial%20Resistance%20Report%202011.pdf
The work of McGeer and Fleming (2012) relates that the evolution of resistance in common hospital pathogens in Ontario has been tracked by QMP-LS since 1996. The 16th annual survey was conducted by QMP-LS in January 2012, which assessed the incidence of resistant hospital pathogens in the province in 2011. All 77 currently licensed bacteriology laboratories are reported to have responded. These laboratories provide services for 211 hospitals. It is reported that resistance in Pseudomonas aeruginosa in 2011 identified "7310/40-110 (18.2%) isolates resistant to ciprofloxacin and 3388/39308 (8.6%) resistant to imipenem/meropenem both of which have increased (from 17.7% and 8.1%, respectively) compared to 2010.Twelve laboratories reporting 9797 isolates of P. aeruginosa were not able to provide data for the number of isolates that were resistant to all agents tested." (p.6)
Breitbach, a.S., Broderick, a.H., Jewell, C.M., Gunasekaran, S., Lin, Q., Lynn, D.M., & Blackwell, H.E. 2010. Surface-mediated release of a synthetic small-molecule modulator of bacterial quorum sensing: Gradual release enhances activity. Chem Comm.
Chun, C.K, Troll, J.V., Koroleva, I., Brown, B., Manzella, L., Snir, E., Almabraz, H, Scheetz, T.E., Bonaldo, M.F., Casavant, T.L., Soares, M.B., Ruby, E.G., & McFall-Ngai, M.J. 2008. Effects of colonization, luminescence, and autoinducer on host transcription during development of the squid-vibrio association. PNAS 105(32): 11323-11328.
Lyell, N.L., Dunn, a.K., Bose, J.L., Stabb, E.V. 2010. Bright mutants of Vibrio fischeri ES114 reveal conditions and regulators that control bioluminescence and expression of the lux Operon. J. Bacteriol. 192(19): 5103-5114.
Murray, P.R., Rosenthal, K.S., Kobayashi, G.S., Pfaller, M.A. 1998. Vibrio, Aeromonas, and Plesiomonas. In M. Brown (Ed.), Medical Microbiology Third Edition (pp. 245-250). St. Louis, MO: Mosby.
Nyholm, S.V., Nishiguchi, M.K. 2008. The evolutionary ecology of a sepiolid squid-vibrio association: from cell to environment. Vie Milieu Paris 58(2): 175-184.
Sea and Sky. 2010. Creatures of the Deep Sea: Deep Sea Bioluminescence. Retrieved from http://www.seasky.org/deep-sea/biolumiscence.html.
Visick, K.L. 2009. An intricate network of regulators controls biofilm formation and colonization by Vibrio fischeri. Molec. Microbiol. 74(4): 782-789.